Targeting vulnerabilities of aneuploid cells for cancer therapy

Area of Science:

• Genomics
• Cancer Biology
• Molecular Oncology

Background:

• Aneuploidy is a hallmark of cancer, driving tumor evolution and creating unique cellular vulnerabilities.
• Recent advances in genomic technologies and experimental models have elucidated diverse cellular consequences of aneuploidy.

Purpose of the Study:

• To review approaches for targeting aneuploid cancer cells.
• To summarize the biological basis of aneuploidy-induced vulnerabilities.
• To explore therapeutic implications for precision oncology.

Main Methods:

• Genomic analysis of cancer cells.
• Functional studies of aneuploidy-induced dependencies.
• Review of current literature on aneuploidy and cancer therapy.

Main Results:

• Aneuploidy confers dependencies on mitotic regulation, DNA replication and repair, proteostasis, metabolism, and immune interactions.
• These dependencies represent potential therapeutic targets in cancer treatment.

Conclusions:

• Targeting aneuploid cells offers a promising strategy for precision oncology.
• Integrating genomic, functional, and clinical data is crucial for translating aneuploidy insights into effective therapies.